The National Human Genome Research Institute (NHGRI) has launched the Population Genomic Screening Network (PGSN), a new five-year consortium bringing together leading institutions—including investigators from G2P and led by Dr. Jason Vassy, Director of G2V —to study the implementation of population genomic screening in primary care. The network will enroll more than 30,000 participants across six clinical sites and evaluate how genomic screening for actionable inherited conditions can be integrated into routine care while improving patient outcomes. Findings from the initiative are expected to inform future clinical practice, implementation strategies, and health policy surrounding preventive genomic medicine.
